GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Express News | Lilly's weight loss medication is now available for purchase on e-commerce platforms in China
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
Court Rules Enanta Patent Invalid in Pfizer Paxlovid Case; Appeal Planned
FDA Approves First Generic of Novo Nordisk's Victoza
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Eli Lilly Stock Is Rising Monday: What's Going On?